KLK3 and prostate carcinoma: Compared to controls, PCa cases were more likely to have a family history of prostate cancer (11.4% versus 6.3%) and PSA levels ≥ 4 ng/mL (48.5% versus 6.5%), as depicted in Supplemental Table A.